A US Food and Drug Administration advisory committee recommended Tuesday that the agency grant emergency use authorization for the Pfizer-BioNTech Covid-19 vaccine for children ages 5 to 11. Next, the FDA decides whether to authorize the vaccine, and then the US Centers for Disease Control and Prevention’s vaccine advisory committee will meet to consider whether it should be recommended for that age group. If CDC Director Dr. Rochelle Walensky signs off on that recommendation, younger children could be getting vaccinated next week.
A US Food and Drug Administration advisory committee recommended Tuesday that the agency grant emergency use authorization for the Pfizer-BioNTech Covid-19 vaccine for children ages 5 to 11. Next, the FDA decides whether to authorize the vaccine, and then the US Centers for Disease Control and Prevention’s vaccine advisory committee will meet to consider whether it should be recommended for that age group. If CDC Director Dr. Rochelle Walensky signs off on that recommendation, younger children could be getting vaccinated next week.